EUVIMEDEUVIMED entdecken
Crossref

Health Equality and Socioeconomic Impact of Hereditary Sensory Neuropathy Type 1 ( HSN1 ) in the UK

Caroline Kramarz iD, Lodina Recica, Jasper Morrow, Mariola Skorupinska, Alexander M Rossor iD, Matilde Laurá, Mary M Reilly iD

Journal of the Peripheral Nervous System · 2026-06 · 31 (2)

DOI: 10.1111/jns.70133 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the Peripheral Nervous System, online erschienen am 02.06.2026. Verfasst von Caroline Kramarz und 6 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Neuromuscular Diseases, Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology and National Hospital for Neurology …. Hauptthemen laut MEDLINE: Cost of Illness, Hereditary Sensory and Autonomic Neuropathies, Health Services Accessibility, Employment. Die Arbeit nennt 7 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims Hereditary Sensory Neuropathy Type 1 (HSN1) is a rare autosomal dominant neuropathy caused by variants in the SPTLC1 and SPTLC2 genes, resulting in sensory loss, motor weakness, chronic ulceration, and risk of limb amputation. Whilst the clinical manifestations are well characterised, the socioeconomic and psychosocial impact remains under‐researched and poorly understood. This pilot study aimed to assess the health equality and socioeconomic impact of HSN1 on affected individuals in the UK.

Methods

A novel 28‐item anonymised questionnaire focusing on employment, healthcare access, finance, mobility, and wellbeing was distributed to 50 genetically confirmed HSN1 patients from an UK cohort. Responses were collected electronically. Quantitative and qualitative data were analysed descriptively.

Results

A total of 37 participants (74%) responded. Of these, only 24% were in full‐time work, with 24% taking early medical retirement. Nearly half (46%) felt the disease negatively impacted career progression. Although 49% requested workplace adjustments, responses were mixed, with some reporting inadequate or denied support. Healthcare access was inconsistent due to long wait times, restrictive referral criteria, and poor awareness of HSN1 outside specialist centres. Financial strain was common; 41% reported income loss, and 21% spent over £1000 annually on disease‐related costs. Driving ability was affected in 48%, and over half reported reduced participation in social activities. Nearly half believed healthcare professionals lacked sufficient understanding of the disease.

Interpretation

HSN1 imposes a substantial burden beyond physical symptoms, affecting employment, finances, independence, and mental health. These results highlight the need for better patient‐centred care and improved education for non‐specialist healthcare professionals. This is particularly timely in the context of emerging disease‐modifying therapies such as L‐serine and future gene therapy trials. Trial Registration: SENSE trial NCT06113055.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cost of IllnessHereditary Sensory and Autonomic NeuropathiesHealth Services AccessibilityEmploymentHumansFemaleUnited KingdomMaleMiddle AgedAdultPilot ProjectsSocioeconomic Disparities in HealthAgedYoung Adult

Stichwörter der Autor:innen

hereditary sensory neuropathyquality of lifesocioeconomic

Autor:innen und Institutionen

  • Centre for Neuromuscular Diseases, Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology and National Hospital for Neurology and Neurosurgery, London, UK.

ORCID-Profile: Caroline Kramarz, Alexander M Rossor, Mary M Reilly

Zitieren

APA

Kramarz, C., Recica, L., Morrow, J., Skorupinska, M., Rossor, A. M., Laurá, M., & Reilly, M. M. (2026). Health Equality and Socioeconomic Impact of Hereditary Sensory Neuropathy Type 1 ( HSN1 ) in the UK. Journal of the Peripheral Nervous System, 31(2). https://doi.org/10.1111/jns.70133

Vancouver

Kramarz C, Recica L, Morrow J, Skorupinska M, Rossor AM, Laurá M, et al. Health Equality and Socioeconomic Impact of Hereditary Sensory Neuropathy Type 1 ( HSN1 ) in the UK. Journal of the Peripheral Nervous System. 2026;31(2). doi:10.1111/jns.70133

BibTeX
@article{Kramarz2026,
  author = {Kramarz, Caroline and Recica, Lodina and Morrow, Jasper and Skorupinska, Mariola and Rossor, Alexander M and Laurá, Matilde and Reilly, Mary M},
  title = {Health Equality and Socioeconomic Impact of Hereditary Sensory Neuropathy Type 1 ( HSN1 ) in the UK},
  journal = {Journal of the Peripheral Nervous System},
  year = {2026},
  volume = {31},
  number = {2},
  doi = {10.1111/jns.70133}
}
Kostenlos starten →